7000 Cardinal Place
478 articles with Cardinal Health
Modern radiation therapy is tightly targeted to dramatically reduce toxicity and side effects and often can be administered on an outpatient basis.
Teva Pharmaceuticals reached a $15 million agreement with the state of Louisiana to settle claims against the company over its marketing of opioid products.
Cardinal Health plans to release first-quarter financial results for its fiscal year 2022 on November 9 prior to the opening of trading on the New York Stock Exchange.
Cardinal Health reported that fourth-quarter fiscal 2021 revenue increased 16% to $42.6 billion.
Total payment amounts are contingent on the number of governments that will agree to suspend their lawsuits as part of the deal.
Cardinal Health to Webcast Discussion of Fourth-Quarter and Year-End Results for Fiscal Year 2021 on August 5
Cardinal Health plans to release fourth-quarter and year-end financial results for its fiscal year 2021 on August 5 prior to the opening of trading on the New York Stock Exchange.
Cardinal Health™ Nuclear & Precision Health Solutions Receives U.S. Food and Drug Administration Approval for New LYMPHOSEEK® Pediatric Indication
Cardinal Health (NYSE: CAH) today announced that LYMPHOSEEK ® has been approved for pediatric use by the U.S. Food and Drug Administration (FDA).
Cardinal Health and Telix Launch Gallium Awareness Campaign With Release of White-Paper: “Moving Beyond the Myth”
As interest and demand for more accurate prostate cancer imaging grows, and with the approval of the first Ga-68 PSMA based prostate imaging agent late last year1, Cardinal Health Nuclear & Precision Health Solutions and Telix Pharmaceuticals Inc. have developed an in-depth white-paper, entitled: “Moving beyond the Myth: Meeting the growing demand for Ga-68 radiopharmaceuticals.”
Cardinal Health announced that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 3.200% notes due June 2022 that are outstanding as of the early redemption date and $262,442,000 in aggregate principal amount of the Company's 2.616% notes due June 2022.
Theranos founder Elizabeth Holmes is back in the courtroom for the first time in 15 months for a three-day hearing ahead of her criminal fraud trial.
Cardinal Health was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services could reach $91.6 million, for the storage and distribution of 80,000 pallets of personal protective equipment to support the Strategic National Stockpile, part of the Office of the Assistant Secretary for Preparedness and Response within HHS.
Cardinal Health plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange.
Cardinal Health announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman for approximately $1 billion, which includes buyer's assumption of certain liabilities and seller's retention of certain working capital accounts.
Cardinal Health collaborates with HIMSS Analytics® as Certified Organization of new CISOM maturity model
WaveMark™ Supply Management & Workflow Solutions to help health systems improve outcomes through clinically integrated supply chain model
Cardinal Health launches TotalVue™ Analytics, a logistics management tool powered by data to drive cost savings
OptiFreight® Logistics, a Cardinal Health company, announced the launch of TotalVue™ Analytics — a tool for healthcare supply chain leaders to utilize predictive technology and data to identify logistics savings and benchmarking.
Cardinal Health is pleased to have been selected by the Ohio Department of Health to support its efforts to distribute COVID-19 vaccines by arranging transportation within the state of Ohio.
GAAP(1) operating loss was $624 million due to an incremental $1.0 billion pre-tax accrual related to opioid litigation; non-GAAP operating earnings increased 7% to $618 million
Cardinal Health plans to release first-quarter financial results for its fiscal year 2021 on November 5 prior to the opening of trading on the New York Stock Exchange.
Cardinal Health reported fourth quarter fiscal year 2020 revenues of $36.7 billion, a decrease of 2 percent from the fourth quarter last year.
Cardinal Health to Webcast Discussion of Fourth-Quarter and Year-End Results for Fiscal Year 2020 on August 6
Cardinal Health plans to release fourth-quarter and year-end financial results for its fiscal year 2020 on August 6 prior to the opening of trading on the New York Stock Exchange.